Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Maia Biotechnology, Inc.

NYSE: MAIA · Life Sciences · 4 alerts · CIK 1878313

Share price
$1.01Close, Nov 16
Market cap
$62.4M
Shares outstanding
61.75MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Maia Biotechnology, Inc. filings on SEC EDGAR ↗

9:01 AM ET 8-K
Clinical Trial Data

Maia Biotechnology Clinical Trial Data

MAIA Biotechnology reported updated interim efficacy data from Part C of its Phase 2 THIO-101 expansion trial evaluating ateganosine (THIO) in patients with advanced non-small cell lung cancer (NSCLC). The trial demonstrated an 88% disease control rate (DCR) in third-line patients who had progressed after prior immunotherapy and chemotherapy, significantly higher than the 25-35% DCR typically seen with standard chemotherapy.

5:07 PM ET 10-Q
Financial Results

Maia Biotechnology Q3 2026 Results: Net Loss of $7.18M, Loss Narrows

For the nine months ended September 30, 2026, MAIA Biotechnology reported a net loss of $21.5 million, driven by $23.3 million in operating expenses. The company significantly strengthened its cash position to $21.3 million, up from $8.7 million at year-end 2025, primarily through a public offering that raised approximately $31.0 million.

Key figure
Net loss $7.18M
8:16 AM ET 8-K
Investor Presentation

Maia Biotechnology Investor Presentation

MAIA Biotechnology, Inc. has prepared and posted a new corporate investor presentation and a summary highlighting its operations and performance to its website. Management intends to use these materials for upcoming presentations to investors and analysts starting October 6, 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.